Agios Pharmaceuticals Gains EU Approval for PYRUKYND in Adult Thalassaemia
Avanzanite Bioscience B.V., one of the rapidly growing commercial-stage European speciality pharmaceutical company focused on rare diseases, on May 22nd reported that its partner, Agios Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for […]
Avanzanite Bioscience Appoints Dr. Mark Bechter as SVP of Medical Affairs
Avanzanite Bioscience B.V., a rapidly growing commercial-stage European speciality pharmaceutical company focused on rare diseases, announced on 10th September the appointment of Dr. Mark Bechter as Senior Vice President of Medical Affairs. As the sixth executive leadership hire of 2025, this appointment further strengthens Avanzanite’s “Champions League” team. It also underscores the company’s commitment to […]
GEDi Cube and Renovaro Biosciences enter into an agreement
GEDi Cube Intl Ltd., an AI medical technology company, and Renovaro Biosciences Inc. (Renovaro), an advanced, preclinical biotechnology firm in cell, gene and immunotherapy, have signed a definitive agreement to combine, in which GEDi Cube will become a wholly-owned subsidiary of Renovaro in a stock-for-stock acquisition (the “Transaction”). If completed, the Transaction will result in […]
ACROBiosystems Aneuro Partners with Diagnostic Biochips
ACROBiosystems, through ACRO Certify and under its Aneuro brand, recently announced the launch of in vivo electrophysiology solutions for neuroscience research with Diagnostic Biochips. Together, two companies are committed to a collaborative effort to accelerate neurological drug discovery and commercialization. Electrophysiology is a critical part of neuroscience research, especially when attempting to elucidate the neural network. Monitoring […]
Acurex Biosciences welcomes Dr. Robert Booth to its Board of Directors
Acurex Biosciences Corporation, a biopharmaceutical company with a mission to stop neurodegeneration before it begins, announces the appointment of renowned biopharmaceutical industry leader Dr. Robert Booth to its Board of Directors. Dr. Booth, distinguished for his invaluable contributions to the biopharmaceutical industry, brings over 30 years of experience in drug discovery, development, and executive leadership. […]
Zivo Bioscience procures USD 1 mln finance for its new coccidiosis product
Zivo Bioscience, Inc., a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, recently announced a $1 million unsecured six-month loan from its Chairman, Chief Executive Officer, and President, John Payne. The loan carries 10% simple interest, may be prepaid without penalty, is extendable for […]
